TISSUE BIOREPOSITORY
TISSUE BIOREPOSITORY
批准号:
8360358
负责人:
DAVID N REISMAN
金额:
$12.02万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2013-05-31
关键词:
Biological ModelsClinicalClinical DataColon CarcinomaCore FacilityDiagnosticFundingGeneticGrantHumanInstitutional Review BoardsLeadMalignant NeoplasmsModelingMolecularNational Center for Research ResourcesOperative Surgical ProceduresOutcomePrimary NeoplasmPrincipal InvestigatorResearchResearch InfrastructureResearch PersonnelResourcesSourceSpecimenTherapeuticTissuesTumor-DerivedUnited States National Institutes of Healthanticancer researchbasebiobankcosthuman tissueinnovationpopulation basedprognostictissue culturetumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
While significant progress in understanding the molecular basis of cancer and cancer progression has been made though the use of tissue culture model systems, these models have clear limitations. The use of human specimens derived from donor matched sets, such as primary tumor and normal adjacent tissue, combined with information of clinical status and outcome, can provide both genetic and population-based information that could be critical for the facilitation of innovation in diagnostics, prognostics and therapeutics as well as towards the understanding of underlying mechanisms that lead to cancer.
The Tissue Biorepository is a newly organized Core Facility of the Center for Colon Cancer Research. It is an IRB-approved biorepository that collects and banks excess surgical specimens. The objective of the Biorepository is to facilitate cancer research by providing high quality normal and tumor-derived human tissue along with robust clinical data to researchers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Establishing BRM Polymorphisms as Predictive Biomarkers for Lung Cancer Risk
-
批准号:8588833
-
项目类别:
-
资助金额:$17.76万
-
财政年份:2013
-
负责人:DAVID N REISMAN
-
依托单位:
Identifying Agents which Restored BRM expression
-
批准号:7995967
-
项目类别:
-
资助金额:$1.18万
-
财政年份:2009
-
负责人:DAVID N REISMAN
-
依托单位:
Identifying Agents which Restored BRM expression
-
批准号:8210867
-
项目类别:
-
资助金额:$29.81万
-
财政年份:2009
-
负责人:DAVID N REISMAN
-
依托单位:
Identifying Agents which Restored BRM expression
-
批准号:8390424
-
项目类别:
-
资助金额:$26.31万
-
财政年份:2009
-
负责人:DAVID N REISMAN
-
依托单位:
Reverse the Epigenetic Suppression of BRM through High Throughput Screening
-
批准号:7761456
-
项目类别:
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:DAVID N REISMAN
-
依托单位:
Identifying Agents which Restored BRM expression
-
批准号:7780209
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2009
-
负责人:DAVID N REISMAN
-
依托单位:
BRM promoter polymorphism, a marker for cancer risks
-
批准号:7532235
-
项目类别:
-
资助金额:$7.73万
-
财政年份:2008
-
负责人:DAVID N REISMAN
-
依托单位:
BRM promoter polymorphism, a marker for cancer risks
-
批准号:7686741
-
项目类别:
-
资助金额:$7.33万
-
财政年份:2008
-
负责人:DAVID N REISMAN
-
依托单位:
Impact of BRG1 Loss in Lung Cancer Development
-
批准号:7501507
-
项目类别:
-
资助金额:$27.4万
-
财政年份:2007
-
负责人:DAVID N REISMAN
-
依托单位:
Impact of BRG1 Loss in Lung Cancer Development
-
批准号:7938815
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:DAVID N REISMAN
-
依托单位:
Impact of BRG1 Loss in Lung Cancer Development
-
批准号:7666712
-
项目类别:
-
资助金额:$27.84万
-
财政年份:2007
-
负责人:DAVID N REISMAN
-
依托单位:
Impact of BRG1 Loss in Lung Cancer Development
-
批准号:8303359
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2007
-
负责人:DAVID N REISMAN
-
依托单位:
Impact of BRG1 Loss in Lung Cancer Development
-
批准号:8130964
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2007
-
负责人:DAVID N REISMAN
-
依托单位:
Impact of BRG1 Loss in Lung Cancer Development
-
批准号:7248488
-
项目类别:
-
资助金额:$27.4万
-
财政年份:2007
-
负责人:DAVID N REISMAN
-
依托单位:
Alterations of the Human SWI/SNF Complex in Lung Cancer
-
批准号:6661922
-
项目类别:
-
资助金额:$13.77万
-
财政年份:2002
-
负责人:DAVID N REISMAN
-
依托单位:
Alterations of the Human SWI/SNF Complex in Lung Cancer
-
批准号:6945848
-
项目类别:
-
资助金额:$13.77万
-
财政年份:2002
-
负责人:DAVID N REISMAN
-
依托单位:
Alterations of the Human SWI/SNF Complex in Lung Cancer
-
批准号:7114385
-
项目类别:
-
资助金额:$13.77万
-
财政年份:2002
-
负责人:DAVID N REISMAN
-
依托单位:
Alterations of the Human SWI/SNF Complex in Lung Cancer
-
批准号:6799310
-
项目类别:
-
资助金额:$13.77万
-
财政年份:2002
-
负责人:DAVID N REISMAN
-
依托单位:
Alterations of the Human SWI/SNF Complex in Lung Cancer
-
批准号:6365256
-
项目类别:
-
资助金额:$13.77万
-
财政年份:2002
-
负责人:DAVID N REISMAN
-
依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位: